MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 1405-86-3
MCE 国际站:Glycyrrhizic acid
产品活性:Glycyrrhizic acid 是甘草里面的活性成分三萜皂苷,为 HMGB1 的拮抗剂,有用于肿瘤、糖尿病等研究的潜力。
研究领域:Anti-infection
作用靶点:Virus Protease
结构分类:萜类 | 三萜 | 结构分类
来源:植物 | 豆科 | 甘草
In Vitro: Glycyrrhizic acid shows a series of anti-cancer-related pharmacological activities, such as broad-spectrum anti-cancer ability, resistance to the tissue toxicity caused by chemotherapy and radiation, drug absorption enhancing effects and anti-multidrug resistance (MDR) mechanisms, as a carrier material in drug delivery systems.
In intestinal NCI-H716 cells that secretes GLP-1, Glycyrrhizic acid promotes GLP-1 secretion with a marked elevation of calcium levels. Glycyrrhizic acid can enhance GLP-1 secretion through TGR5 activation.
Glycyrrhizic acid can form a stable transparent low-molecular-weight hydrogels (LMWHs) at 37°C in physiological phosphate buffered saline (PBS) with nanoclusters as the microstructures.
In Vivo: In type 1-like diabetic rats induced by streptozotocin (STZ-treated rats), Glycyrrhizic acid increases the level of plasma GLP-1, which is blocked by triamterene at a dose sufficient to inhibit Takeda G-protein-coupled receptor 5 (TGR5).
Glycyrrhizic acid (Glycyrrhizic acid; 50 mg/kg, i.p.) significantly decreases the levels of TgAb, HMGB1, TNF-α, IL-6, IL-1β in mice.
相关产品:Natural Product Library Plus | Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Anti-Infection Compound Library | Natural Product Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Antiviral Compound Library | Drug Repurposing Compound Library | Anti-diabetic Compound Library | Glycoside Compound Library | Anti-COVID-19 Compound Library | NMPA-Approved Drug Library | Medicine Food Homology Compound Library | Terpenoids Library | Pyroptosis Compound Library | Traditional Chinese Medicine Active Compound Library | FDA Approved & Pharmacopeial Drug Library | Drug-Induced Liver Injury (DILI) Compound Library | Transcription Factor-Targeted Library | Food Additive Library | Food-Sourced Compound Library | Rare Diseases Drug Library | Anti-Cancer Natural Product Library | Protein-protein Interaction Inhibitor Library | Antiviral Traditional Chinese Medicine Active Compound Library | Plant-Sourced Natural Product Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Non-steroidal Anti-Inflammatory Compound Library | Off-patent Drug Library | SRPIN340 | Aminothiazole | SP inhibitor 1 | Genkwanin | L-Lysine-15N2 hydrochloride | Aspirin-d4 | (-)-α-Pinene | 2'-Deoxy-2'-fluoro-l-uridine | LabMol-319 | 4E2RCat | HCVcc-IN-1 | ZIKV-IN-1 | HCVcc-IN-2 | Mpro inhibitor N3 | ESI-09 | Tubacin | 2-Phenylethanol-d9 | L-Lysine-13C6 dihydrochloride | Phenytoin | ML188 | N-Desmethylclozapine | DENV-IN-8 | ZIKV-IN-3 | Encephalitic alphavirus-IN-1 | Plerixafor octahydrochloride | 4-Phenylbutyric acid-d11 | SID-852843 | NS2B/NS3-IN-3 | (-)-Epicatechin gallate
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。